[2160]ジーエヌアイ:【遺伝子解析】製薬会社と共同で中国で新薬開発も

Yahoo! 【グロース/08医薬品】 売上高:236110 当期純利益:10980 総資産:719420 時価:1168億円

株価

日付初値高値安値終値出来高出来高比前日比upvlogic抽出5%日数高値下落底値上昇
202511062,4792,5622,4752,522840,900-202,100102%▲228208100%8%
202511072,4852,5352,4552,511633,600-207,300100%▼88280799%8%
202511102,5432,5722,5132,566698,80065,200102%▲111100100%10%
202511112,5502,5542,4782,5061,017,500318,70098%▼77170098%6%
202511122,4912,5412,4802,541723,700-293,800101%▲82820499%8%
202511132,5212,5412,5032,515594,900-128,80099%▼52280398%7%
202511142,4622,5242,4602,507919,100324,200100%▼▼77770298%6%
202511172,5152,6672,5002,6531,744,000824,900106%▲111101100%12%
202511182,6132,6432,4452,4482,044,500300,50092%▼77170092%4%
202511192,4342,4652,3552,4141,229,900-814,60099%▼▼88880791%2%
202511202,4602,4822,3832,4601,159,800-70,100102%▲22220093%4%
202511212,3862,4832,3722,4331,124,900-34,90099%▼28880392%1%
202511252,4502,5222,3962,4061,079,200-45,70099%▼▼22280091%0%
202511262,4172,6122,4082,5361,730,100650,900105%▲11710296%6%
202511272,5262,5662,4782,555829,200-900,900101%▲▲82220096%6%
202511282,5302,6142,5252,569871,00041,800101%▲▲▲111140097%7%
202512012,5432,5632,4652,476969,30098,30096%▼77170093%3%
202512022,4632,5372,4182,4181,144,600175,30098%▼▼77770091%0%
202512032,3902,4082,1922,2403,519,1002,374,50093%▼▼▼777724084%0%
202512042,2332,3272,2152,3091,596,700-1,922,400103%▲82820087%3%
202512052,3202,3792,2942,3291,046,600-550,100101%▲▲22220088%4%

    TDNET

    strdate時間企業名タイトルurl
    2025111416:00Ｇ－ＧＮＩ 2025年12月期 第3四半期決算短信〔IFRS〕（連結）
    2025111416:00Ｇ－ＧＮＩ2025年12月期 第3四半期ファクトブック
    2025111416:00Ｇ－ＧＮＩ2025年12月期 第3四半期決算説明資料
    2025101609:00Ｇ－ＧＮＩ（開示事項の経過）主要子会社 Gyre Therapeutics によるじん肺治療を対象とした ピルフェニドンの第３相臨床試験における被験者登録完了のお知らせ
    2025091908:30Ｇ－ＧＮＩ（開示事項の経過）主要子会社Cullgenが開発する新規非オピオイド鎮痛薬候補CG001419の第１相臨床試験における被験者登録完了のお知らせ

      機関空売り

      報告日コード機関名残高率残高増減
      2025-12-032160Barclays Capital Securities Ltd379,5431%▲
      2025-12-032160GOLDMAN SACHS INTERNATIONAL685,7461%▼-194,500
      2025-12-032160MERRILL LYNCH INTERNATIONAL503,5671%▼-88,700
      2025-12-032160モルガン・スタンレーMUFG証券株式会社1,092,1522%▼-58,400
      2025-12-032160野村證券株式会社390,6651%▲48,600
      2025-12-022160GOLDMAN SACHS INTERNATIONAL880,2462%▲51,600
      2025-12-022160モルガン・スタンレーMUFG証券株式会社1,150,5522%▼-25,400
      2025-12-012160Arrowstreet Capital, Limited Partnership509,9501%▲51,400
      2025-12-012160MERRILL LYNCH INTERNATIONAL592,2671%▼-34,500
      2025-12-012160モルガン・スタンレーMUFG証券株式会社1,175,9522%▲21,400
      2025-11-282160Citigroup Global Markets Limited382,8811%▼-33,800
      2025-11-282160MERRILL LYNCH INTERNATIONAL626,7671%▲9,000
      2025-11-272160MERRILL LYNCH INTERNATIONAL617,7671%▲17,600
      2025-11-262160GOLDMAN SACHS INTERNATIONAL828,6461%▼-37,400
      2025-11-262160MERRILL LYNCH INTERNATIONAL600,1671%▼-128,700
      2025-11-262160モルガン・スタンレーMUFG証券株式会社1,154,5522%▼-46,400
      2025-11-252160GOLDMAN SACHS INTERNATIONAL866,0462%▲87,800
      2025-11-252160MERRILL LYNCH INTERNATIONAL728,8671%▼-38,200
      2025-11-212160Citigroup Global Markets Limited416,6811%▲104,300
      2025-11-212160GOLDMAN SACHS INTERNATIONAL778,2461%▼-16,800
      2025-11-212160MERRILL LYNCH INTERNATIONAL767,0671%▼-20,200
      2025-11-202160Arrowstreet Capital, Limited Partnership458,5501%▲42,800
      2025-11-202160GOLDMAN SACHS INTERNATIONAL795,0461%▼-82,700
      2025-11-192160Citigroup Global Markets Limited312,3811%▼-63,800
      2025-11-192160MERRILL LYNCH INTERNATIONAL787,2671%▼-52,700
      2025-11-182160GOLDMAN SACHS INTERNATIONAL877,7462%▼-33,000
      2025-11-182160MERRILL LYNCH INTERNATIONAL839,9672%▲150,500
      2025-11-172160GOLDMAN SACHS INTERNATIONAL910,7462%▼-81,800
      2025-11-172160MERRILL LYNCH INTERNATIONAL689,4671%▲17,800
      2025-11-172160モルガン・スタンレーMUFG証券株式会社1,200,9522%▼-45,400

        信用取引

        日付買残ALL売残ALL一般買残一般売残制度買残制度売残
        2025-11-287,033,000902,6004,918,5009002,114,500901,700
        2025-11-217,152,100844,7004,902,2009002,249,900843,800
        2025-11-147,237,700846,0004,975,8009002,261,900845,100
        2025-11-077,342,900847,7005,057,1009002,285,800846,800

          EDINET

          日付docID提出者タイトル
          2025-07-31 14:09S100WEUJＹＩＮＧ　ＬＵＯ変更報告書